Literature DB >> 21519997

Glucose transporter expression of intraductal papilloma of the breast detected by fluorodeoxyglucose positron emission tomography.

Yasumitsu Hirose1, Hayato Kaida, Masatoshi Ishibashi, Akihiko Kawahara, Maiko Kobayashi, Naofumi Hayabuchi.   

Abstract

A 40-year-old woman discovered through palpation a tumor in the upper lateral quadrant of the left mammary gland. Mammography, ultrasonography (US), and magnetic resonance imaging (MRI) showed a 10 mm diameter tumor. Fluorine-18 fluorodeoxyglucose positron emission tomography ((18)F-FDG-PET) showed abnormal accumulation in the detected tumor, and the maximum standardized uptake value was 2.2. The patient underwent tumor resection. The postoperative histopathological finding was intraductal papilloma. The intraductal papilloma showed strong expression of glucose transporter (GLUT)-4 on membrane and/or cytoplasm, and weak expression of GLUT-1 and GLUT-3 by immunohistochemistry. This case suggests that other glucose transporters (e.g., GLUT-4), other pathological factors, and cytokines may have a close relation with (18)F-FDG accumulation in intraductal papilloma more than GLUT-1 or GLUT-3 expression.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21519997     DOI: 10.1007/s11604-010-0531-0

Source DB:  PubMed          Journal:  Jpn J Radiol        ISSN: 1867-1071            Impact factor:   2.374


  10 in total

1.  Intraductal papilloma of the breast: F-18 FDG PET demonstration.

Authors:  Ba D Nguyen; Thomas K Lidner
Journal:  Clin Nucl Med       Date:  2005-07       Impact factor: 7.794

2.  Differential expression of glucose transporters in normal and pathologic thyroid tissue.

Authors:  Kenichi Matsuzu; Fernando Segade; Utako Matsuzu; Aaron Carter; Donald W Bowden; Nancy D Perrier
Journal:  Thyroid       Date:  2004-10       Impact factor: 6.568

3.  F-18 fluorodeoxyglucose uptake in leiomyomatous uterus.

Authors:  M Shida; M Murakami; H Tsukada; Y Ishiguro; K Kikuchi; E Yamashita; H Kajiwara; M Yasuda; M Ide
Journal:  Int J Gynecol Cancer       Date:  2007 Jan-Feb       Impact factor: 3.437

4.  Positherapy: targeted nuclear therapy of breast cancer with 18F-2-deoxy-2-fluoro-D-glucose.

Authors:  Renee M Moadel; Richard H Weldon; Ellen B Katz; Ping Lu; Joseph Mani; Mark Stahl; M Donald Blaufox; Richard G Pestell; Maureen J Charron; Ekaterina Dadachova
Journal:  Cancer Res       Date:  2005-02-01       Impact factor: 12.701

5.  Abnormal fluorine-18-fluorodeoxyglucose uptake in benign esophageal leiomyoma.

Authors:  Kentaroh Miyoshi; Minoru Naito; Tsuyoshi Ueno; Shinji Hato; Hideo Ino
Journal:  Gen Thorac Cardiovasc Surg       Date:  2009-11-12

6.  Standardized uptake values of uterine leiomyoma with 18F-FDG PET/CT: variation with age, size, degeneration, and contrast enhancement on MRI.

Authors:  Kazuhiro Kitajima; Koji Murakami; Erena Yamasaki; Yasushi Kaji; Kazuro Sugimura
Journal:  Ann Nucl Med       Date:  2008-08-01       Impact factor: 2.668

7.  Papillary tumors of large lactiferous ducts.

Authors:  T M Murad; G Contesso; H Mouriesse
Journal:  Cancer       Date:  1981-07-01       Impact factor: 6.860

8.  Improved breast cancer detection of prone breast fluorodeoxyglucose-PET in 118 patients.

Authors:  Hayato Kaida; Masatoshi Ishibashi; Teruhiko Fuji; Seiji Kurata; Masafumi Uchida; Kenkichi Baba; Teruo Miyagawa; Hiroko Kaibara; Seiji Kawamura; Etsuyo Ogo; Naofumi Hayabuchi
Journal:  Nucl Med Commun       Date:  2008-10       Impact factor: 1.690

9.  (18)F-FDG PET analysis of schwannoma: increase of SUVmax in the delayed scan is correlated with elevated VEGF/VPF expression in the tumors.

Authors:  Kenichiro Hamada; Yasuhiko Tomita; Ying Qiu; Miki Tomoeda; Takafumi Ueda; Noriyuki Tamai; Nobuyuki Hashimoto; Hideki Yoshikawa; Katsuyuki Aozasa; Jun Hatazawa
Journal:  Skeletal Radiol       Date:  2008-12-17       Impact factor: 2.199

10.  18F-fluorodeoxyglucose and PET/CT for noninvasive study of exercise-induced glucose uptake in rat skeletal muscle and tendon.

Authors:  Dorthe Skovgaard; Michael Kjaer; Henrik El-Ali; Andreas Kjaer
Journal:  Eur J Nucl Med Mol Imaging       Date:  2009-01-10       Impact factor: 9.236

  10 in total
  4 in total

Review 1.  Present and future role of FDG-PET/CT imaging in the management of breast cancer.

Authors:  Kazuhiro Kitajima; Yasuo Miyoshi
Journal:  Jpn J Radiol       Date:  2016-01-05       Impact factor: 2.374

2.  The Synergistic Effect of Selumetinib/Docetaxel Combination Therapy Monitored by [(18)F]FDG/[(18)F]FLT PET and Diffusion-Weighted Magnetic Resonance Imaging in a Colorectal Tumor Xenograft Model.

Authors:  Valerie S Honndorf; Holger Schmidt; Stefan Wiehr; Hans F Wehrl; Leticia Quintanilla-Martinez; Anke Stahlschmidt; Hervé Barjat; Sally-Ann Emmas; Bernd J Pichler
Journal:  Mol Imaging Biol       Date:  2016-04       Impact factor: 3.488

Review 3.  Glucose transporters in cancer metabolism.

Authors:  Kehinde Adekola; Steven T Rosen; Mala Shanmugam
Journal:  Curr Opin Oncol       Date:  2012-11       Impact factor: 3.645

4.  Spectrum of the Breast Lesions With Increased 18F-FDG Uptake on PET/CT.

Authors:  Aisheng Dong; Yang Wang; Jianping Lu; Changjing Zuo
Journal:  Clin Nucl Med       Date:  2016-07       Impact factor: 7.794

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.